Skip to search formSkip to main contentSkip to account menu

Priorix

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Measles-Mumps-Rubella Vaccine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
The how’s and what’s of vaccine reactogenicity
Reactogenicity represents the physical manifestation of the inflammatory response to vaccination, and can include injection-site… 
Highly Cited
2015
Highly Cited
2015
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.
Highly Cited
2014
Highly Cited
2014
Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination.
Review
2011
Review
2011
Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.
2011
2011
Persistence of Immunity Following a Booster Dose of Haemophilus Influenzae Type B-Meningococcal Serogroup C Glycoconjugate Vaccine: Follow-up of a Randomized Controlled Trial
Background: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) wane after early… 
Review
2010
Review
2010
Comparative varicella vaccine effectiveness during outbreaks in day-care centres.
Highly Cited
2010
Highly Cited
2010
Influenza vaccine concurrently administered with a combination measles, mumps, and rubella vaccine to young children.
Review
2009
Review
2009
Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled…
2004
2004
Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children.
2000
2000
Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)